Ziluta 150mg

Ziluta 150mg is a prescription medication used to treat prostate cancer, specifically in men with stage III or IV disease. It is an anti-androgen medication that works by blocking the action of androgens (male hormones) in the body, which can help slow the growth of prostate cancer.

Composition:

• Ziluta 150mg: Nilutamide 150mg Tablet

Mechanism of Action:

Nilutamide, the active ingredient in Ziluta, works by:

1. Binding to androgen receptors in the body, which blocks the action of androgens (male hormones).
2. Reducing the production of androgens in the body, which can help slow the growth of prostate cancer.
3. Inhibiting the growth of prostate cancer cells by blocking the action of androgens.

Indications:

Ziluta is approved for the treatment of prostate cancer in men with:

1. Stage III disease, who have not responded to or have progressed on other therapies.
2. Stage IV disease, who have not responded to or have progressed on other therapies.

Dosage:

The recommended dosage of Ziluta is:

• 150mg orally once daily, for at least 30 days after treatment has stopped.

Side Effects:

Common side effects of Ziluta include:

1. Fatigue
2. Nausea
3. Vomiting
4. Diarrhea
5. Abdominal pain
6. Headache
7. Dizziness
8. Muscle weakness
9. Skin rash
10. Increased risk of depression

Recommendation:

Ziluta is recommended for men with stage III or IV prostate cancer who have not responded to or have progressed on other therapies.

Important Note:

• Patients taking Ziluta should be closely monitored for signs of depression, anxiety, or other mood changes.
• Patients taking Ziluta should avoid taking medications that may interact with it, such as anticoagulants or medications that can increase blood pressure.
• Pregnant or breastfeeding women should not use Ziluta, as it may harm the fetus or infant.
• Regular follow-up appointments with your healthcare provider are necessary to monitor the effectiveness of Ziluta and to detect any potential side effects or complications.

Special Precautions:

• Patients with a history of liver disease or kidney disease should be closely monitored while taking Ziluta.
• Patients taking Ziluta should avoid taking medications that may increase the risk of liver damage or kidney damage.
• Patients with a history of depression or other mood disorders should be closely monitored while taking Ziluta.

Contraindications:

• Patients with severe liver disease or severe kidney disease should not use Ziluta.
• Patients who are pregnant or breastfeeding should not use Ziluta.
• Patients who are allergic to nilutamide or any other component of Ziluta should not use it.